Alexander Eggermont’s directorship of Institut Gustave Roussy extended by 5 years

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

ALEXANDER EGGERMONT, general director of Institut Gustave Roussy since 2010, has had his appointment as head of the institute renewed by the French minister of health for another five years. The institute is one of the largest health centers in Europe dedicated to oncology. The past five years has seen a large investment program at...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login